✦ LIBER ✦

Detection of KRAS Oncogene in Peripheral Blood as a Predictor of the Response to Cetuximab Plus Chemotherapy in Patients with Metastatic Colorectal Cancer

✍ Scribed by Yen, L.-C.; Yeh, Y.-S.; Chen, C.-W.; Wang, H.-M.; Tsai, H.-L.; Lu, C.-Y.; Chang, Y.-T.; Chu, K.-S.; Lin, S.-R.; Wang, J.-Y.

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Clinical relevance of KRAS mutation dete

✍ Di Fiore, F; Blanchard, F; Charbonnier, F; Le Pessot, F; Lamy, A; Galais, M P; B 📂 Article 📅 2007 🏛 Nature Publishing Group 🌐 English ⚖ 99 KB

Biweekly cetuximab plus FOLFIRI/irinotec

✍ Chen, Ye; Cao, Dan; Bi, Feng; Li, Qiu; Qiu, Meng 📂 Article 📅 2014 🏛 Springer US 🌐 English ⚖ 222 KB

Prognostic Value of the Combination of C

✍ Sastre, Javier; Vidaurreta, Marta; Gómez, Auxiliadora; Rivera, Fernando; Massutí 📂 Article 📅 2013 🏛 CIG Media Group, LP. 🌐 English ⚖ 686 KB

P53 Mutations as a possible predictor of

✍ J. Benhattar; J.P. Cerottini; E. Saraga; G. Metthez; J.C. Givel 📂 Article 📅 1996 🏛 Elsevier Science 🌐 English ⚖ 79 KB

A gene expression predictor of response

✍ Justin M Balko; Esther P Black 📂 Article 📅 2009 🏛 BioMed Central 🌐 English ⚖ 657 KB

Effects of KRAS, BRAF, NRAS, and PIK3CA

✍ Wendy De Roock; Bart Claes; David Bernasconi; Jef De Schutter; Bart Biesmans; Ge 📂 Article 📅 2010 🏛 The Lancet 🌐 English ⚖ 384 KB